Publications by authors named "Martin Markowitz"

Claim this Profile
E
Effectiveness of islatravir post-exposure prophylaxis after intravenous challenge with simian immunodeficiency virus in rhesus macaques.
Martin Markowitz, Agegnehu Gettie, Leslie St Bernard, Brooke Grasperge, Ryan Vargo

J Int AIDS Soc· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1.
Nicolas Vabret, Valérie Najburg, Alexander Solovyov, Ramya Gopal, Christopher McClain, Martin Markowitz

iScience· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Resistance Mutation Frequency of Single-Genome Amplification-Derived HIV-1 Polymerase Genomes in the Cerebrospinal Fluid and Plasma of HIV-1-Infected Individuals under Nonsuppressive Therapy.
Leslie St Bernard, Jeremy Abolade, Hiroshi Mohri, Martin Markowitz, Teresa H Evering

J Virol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial.
Mansi Saxena, Rachel L Sabado, Melissa La Mar, Hiroshi Mohri, Andres M Salazar, Martin Markowitz

Front Immunol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-Weekly Oral Dosing of MK-8591 Protects Male Rhesus Macaques From Intrarectal Challenge With SHIV109CP3.
Martin Markowitz, Agegnehu Gettie, Leslie St Bernard, Chasity D Andrews, Hiroshi Mohri

J Infect Dis· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Islatravir for the treatment and prevention of infection with the human immunodeficiency virus type 1.
Martin Markowitz, Jay A Grobler

Curr Opin HIV AIDS· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction: long-acting antiretrovirals for the treatment and prevention of HIV-1 infection: the future is now.
Martin Markowitz

Curr Opin HIV AIDS· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5' Rapid Amplification of cDNA Ends and Illumina MiSeq Reveals B Cell Receptor Features in Healthy Adults, Adults With Chronic HIV-1 Infection, Cord Blood, and Humanized Mice.
Eric Waltari, Manxue Jia, Caroline S Jiang, Hong Lu, Jing Huang, Martin Markowitz

Front Immunol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling the Epidemiological Impact and Cost-Effectiveness of PrEP for HIV Transmission in MSM in China.
Lei Zhang, Peng Peng, Yumeng Wu, Xiaomeng Ma, Nyi Nyi Soe, Martin Markowitz

AIDS Behav· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: Patient perspectives from the ECLAIR trial.
Miranda I Murray, Martin Markowitz, Ian Frank, Robert M Grant, Kenneth H Mayer

HIV Clin Trials· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4'-Ethynyl-2-fluoro-2'-deoxyadenosine, MK-8591: a novel HIV-1 reverse transcriptase translocation inhibitor.
Martin Markowitz, Stefan G Sarafianos

Curr Opin HIV AIDS· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lessons for Patient Education Around Long-Acting Injectable PrEP: Findings from a Mixed-Method Study of Phase II Trial Participants.
Kathrine Meyers, Kristina Rodriguez, Atrina L Brill, Yumeng Wu, Melissa La Mar, Martin Markowitz

AIDS Behav· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabotegravir in the treatment and prevention of Human Immunodeficiency Virus-1.
Tristan D McPherson, Magdalena E Sobieszczyk, Martin Markowitz

Expert Opin Investig Drugs· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Newly Acquired Infection With Multidrug-Resistant HIV-1 in a Patient Adherent to Preexposure Prophylaxis.
Martin Markowitz, Howard Grossman, Peter L Anderson, Robert Grant, Monica Gandhi

J Acquir Immune Defic Syndr· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial.
Martin Markowitz, Ian Frank, Robert M Grant, Kenneth H Mayer, Richard Elion

Lancet HIV· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brief Report: The Relationship Between Injection Drug Use Risk Behaviors and Markers of Immune Activation.
Sherry Deren, Charles M Cleland, Haekyung Lee, Saurabh Mehandru, Martin Markowitz

J Acquir Immune Defic Syndr· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabotegravir long acting injection protects macaques against intravenous challenge with SIVmac251.
Chasity D Andrews, Leslie St Bernard, Amanda Yee Poon, Hiroshi Mohri, Natanya Gettie, Martin Markowitz

AIDS· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic Hepatitis C Virus Infection and the Proinflammatory Effects of Injection Drug Use.
Martin Markowitz, Sherry Deren, Charles Cleland, Melissa La Mar, Evelyn Silva

J Infect Dis· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in Recruiting People Who Use Drugs for HIV-Related Biomedical Research: Perspectives from the Field.
Pedro Batista, Sherry Deren, Angela Banfield, Evelyn Silva, Mario Cruz, Martin Markowitz

AIDS Patient Care STDS· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques.
Manxue Jia, Hong Lu, Martin Markowitz, Cecilia Cheng-Mayer, Xueling Wu

J Virol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population-Level Immune-Mediated Adaptation in HIV-1 Polymerase during the North American Epidemic.
Natalie N Kinloch, Daniel R MacMillan, Anh Q Le, Laura A Cotton, David R Bangsberg, Martin Markowitz

J Virol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rates of non-confounded HIV-associated neurocognitive disorders in men initiating combination antiretroviral therapy during primary infection.
Teresa H Evering, Allison Applebaum, Melissa La Mar, Donald Garmon, David Dorfman, Martin Markowitz

AIDS· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extending access with long-acting antiretroviral therapy: the next advance in HIV-1 therapeutics and prevention.
Martin Markowitz, Kathrine Meyers

Curr Opin HIV AIDS· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal antibodies to host cellular receptors for the treatment and prevention of HIV-1 infection.
Craig Pace, Martin Markowitz

Curr Opin HIV AIDS· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Behavioural, Mucosal and Systemic Immune Parameters in HIV-infected and Uninfected Injection Drug Users.
Saurabh Mehandru, Sherry Deren, Sung-Yeon Kang, Angela Banfield, Aakash Garg, Martin Markowitz

J Addict Res Ther· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis